Avrax
This company is in the pipeline of America 2030, IPO CLUB’s short-term, actively managed secondary fund focused on U.S. defense, energy, security, and AI.
Updated in February 2026
Headquarter: Munich, Germany
Year Founded: 2025
Leadership: Kristijan Vrban (Co-Founder & AI/Software Lead), Miguel Alfonso (Co-Founder & Aerospace Engineering), Mark Zondler (Co-Founder & Business Development)
Industry Sectors: Air-to-air “drone-fired missiles.
Funding Round: Pre-Seed, February 2026
Valuation: Not disclosed
Is Avrax Systems A Public Company? No, it is privately held
What Is Avrax?
AVRAX Systems is a defense technology company developing ultra-light, drone-launched interceptors designed to counter hostile unmanned aerial systems (UAS). The core concept is a reusable carrier drone that can carry multiple AVRAX missiles, allowing a single operator to engage multiple aerial targets in one mission, rather than requiring one pilot per intercept.
Technology & Products
AVRAX’s current product is an autonomous, “fire-and-forget” missile designed to be launched from a carrier drone and guided in terminal flight using onboard edge compute and optical AI (computer vision) for detection, tracking, and final approach. The missile is designed to operate without relying on external terminal guidance links that can be disrupted in contested electronic-warfare environments, and the company is developing day and night configurations via camera module and model variants. AVRAX reports flight-tested prototypes demonstrating autonomous targeting and is progressing toward rocket-powered mid-air launches from quadcopter carrier platforms, alongside third-party carrier integration work.
Market Opportunity
Counter-UAS demand is being driven by the rapid proliferation of low-cost drones and the operational strain they place on legacy air defense. Traditional interceptors are often cost-inefficient for “low/slow/small” targets, while defensive FPV interception can be manpower-limited. Market research firms project rapid growth in counter-UAS spending (e.g., MarketsandMarkets projects the global C-UAS market growing from USD 6.64B in 2025 to USD 20.31B by 2030), reflecting expanding requirements across border protection, base defense, and deployed forces. AVRAX is positioned specifically around high-tempo, high-volume engagement scenarios where cost-per-shot and operator-to-engagement leverage are decisive.
Competitive Landscape
AVRAX competes within a crowded and rapidly evolving counter-UAS ecosystem spanning soft-kill (jamming/EW), ground-based hard-kill interceptors, and airborne interceptor drones. Established defense primes field dedicated counter-UAS interceptors (e.g., Raytheon’s Coyote variants), while newer defense tech companies emphasize autonomous intercept and reusable systems (e.g., Anduril’s Roadrunner). In Europe, incumbents are also moving toward dedicated low-cost anti-drone missiles (e.g., Saab’s Nimbrix). AVRAX’s differentiation is the combination of (i) a drone-launched, multi-missile carrier approach, and (ii) onboard optical autonomy intended to reduce pilot workload and reliance on contested links—while facing the same key commercialization gate as peers: proving repeatable engagement performance and navigating safety, integration, and procurement qualification.
How To Buy Avrax Stock?
Avrax is currently a private company and is not publicly traded on major stock exchanges like the NASDAQ or NYSE. This means you can buy shares through a pre-IPO platform or brokerage like IPO CLUB by becoming a FREE MEMBER.
This company is in the pipeline of America 2030, IPO CLUB’s short-term, actively managed secondary fund focused on U.S. defense, energy, security, and AI.
FAQ
AVRAX Systems is a private company, and IPO CLUB access—when available—is generally structured for accredited investors through secondary allocations such as the America 2030 fund pipeline and/or Single-Name SPVs. Availability is not guaranteed and depends on secondary-market supply and seller willingness.
- You must qualify as an accredited investor / qualified purchaser under IPO CLUB’s platform constraints.
- AVRAX Systems is described as in the pipeline of America 2030 (not necessarily a live/open allocation).
- If a deal becomes available, participation is commonly via America 2030 and/or a Single-Name SPV structure.
AVRAX Systems access on IPO CLUB can change, and the page currently frames the company as being in the America 2030 pipeline rather than promising an open allocation. Checking “Live Deals” via membership/login is typically how availability is verified on the platform.
- Pipeline status ≠ confirmed allocation; supply can be limited or absent.
- Secondary availability depends on seller participation and transferability.
- IPO CLUB participation is constrained to accredited investors / qualified purchasers.
AVRAX Systems is not publicly traded and does not have a public stock ticker, because it is privately held. Any exposure discussed on IPO CLUB would therefore be pre-IPO/private and typically secondary in nature for accredited investors.
- No public-market price discovery (no NYSE/Nasdaq listing).
- Private transactions, if available, can be illiquid and transfer-restricted.
- Access (if any) is generally framed via America 2030 and/or Single-Name SPVs.
AVRAX Systems availability on IPO CLUB primarily depends on secondary-market supply, seller willingness, and whether transfers can be completed under the relevant terms and restrictions. The company is presented as being in the America 2030 pipeline, which signals monitoring/coverage rather than guaranteed inventory.
- Secondary supply can be sporadic and oversubscribed.
- Transfers may require approvals and can be blocked by company or contractual restrictions.
- Platform participation is limited to accredited investors / qualified purchasers.
AVRAX Systems exposure on IPO CLUB—when offered—is typically provided via structured vehicles used for curated secondary allocations, such as the America 2030 fund and Single-Name SPVs for accredited investors. The final structure can vary by deal and seller terms.
- Single-Name SPVs may be used to pool participation.
- Investors often receive an interest in a vehicle rather than a direct line-item of common shares (structure varies).
- Eligibility constraints: accredited investors / qualified purchasers only.
AVRAX Systems allocations may fail to confirm because secondary supply can change quickly and transfers can be delayed or blocked by documentation, approvals, or changing seller terms. IPO CLUB also does not promise availability, particularly for companies described as pipeline names.
- Seller can reduce/withdraw supply or reprice before close.
- Transfer restrictions/approval processes can prevent completion.
- Oversubscription can force allocation downsizing.
AVRAX Systems pre-IPO investing can be high-risk and illiquid, and IPO CLUB participation is constrained to accredited investors / qualified purchasers. Because AVRAX Systems is privately held, liquidity events (if any) may be unpredictable.
- Liquidity risk: you may not be able to sell quickly (or at all) at a desired price.
- Transfer/execution risk: approvals or restrictions can delay or block closings.
- Information risk: AVRAX Systems is early-stage (pre-seed noted on the page) and valuation is not disclosed.
AVRAX Systems is described as pre-seed (February 2026), and its valuation is listed as “not disclosed” on the IPO CLUB page. As a result, any access discussion should not assume a price or round terms without deal-specific documentation.
- Funding stage shown: Pre-Seed, February 2026.
- Valuation shown: Not disclosed.
- Any investment access (if available) remains subject to accredited investor / qualified purchaser constraints and secondary supply.
CesiumAstro and America 2030 Latest News
Stay up-to-date with all the latest news pertaining to this company’s stock, IPO, and investment opportunity. By clicking here, you'll gain access to real-time updates and in-depth analysis from market experts, empowering you to make informed decisions about your investment journey. Whether you're a seasoned investor or just getting started, our platform is tailored to provide you with all the crucial information you need to navigate the thrilling world of the stock market and IPOs. Dive in and keep your finger on the pulse of the financial markets.
The article summarizes each company’s jurisdiction, reactor technology, fuel type, development stage, and most recently disclosed valuation, based on publicly available information and industry disclosures as of 2024–2026.